» Articles » PMID: 33036430

Fructose Consumption by Adult Rats Exposed to Dexamethasone In Utero Changes the Phenotype of Intestinal Epithelial Cells and Exacerbates Intestinal Gluconeogenesis

Overview
Journal Nutrients
Date 2020 Oct 10
PMID 33036430
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Fructose consumption by rodents modulates both hepatic and intestinal lipid metabolism and gluconeogenesis. We have previously demonstrated that in utero exposure to dexamethasone (DEX) interacts with fructose consumption during adult life to exacerbate hepatic steatosis in rats. The aim of this study was to clarify if adult rats born to DEX-treated mothers would display differences in intestinal gluconeogenesis after excessive fructose intake. To address this issue, female Wistar rats were treated with DEX during pregnancy and control (CTL) mothers were kept untreated. Adult offspring born to CTL and DEX-treated mothers were assigned to receive either tap water (Control-Standard Chow (CTL-SC) and Dexamethasone-Standard Chow (DEX-SC)) or 10% fructose in the drinking water (CTL-fructose and DEX-fructose). Fructose consumption lasted for 80 days. All rats were subjected to a 40 h fasting before sample collection. We found that DEX-fructose rats have increased glucose and reduced lactate in the portal blood. Jejunum samples of DEX-fructose rats have enhanced phosphoenolpyruvate carboxykinase (PEPCK) expression and activity, higher facilitated glucose transporter member 2 (GLUT2) and facilitated glucose transporter member 5 (GLUT5) content, and increased villous height, crypt depth, and proliferating cell nuclear antigen (PCNA) staining. The current data reveal that rats born to DEX-treated mothers that consume fructose during adult life have increased intestinal gluconeogenesis while recapitulating metabolic and morphological features of the neonatal jejunum phenotype.

Citing Articles

Low Birth Weight Intensifies Changes in Markers of Hepatocarcinogenesis Induced by Fructose Consumption in Rats.

Almeida L, Jordao Teixeira C, Campos C, Casaloti L, Sodre F, Capetini V Metabolites. 2022; 12(10).

PMID: 36295788 PMC: 9608855. DOI: 10.3390/metabo12100886.


Dietary Plant-Origin Bio-Active Compounds, Intestinal Functionality, and Microbiome.

Tako E Nutrients. 2020; 12(11).

PMID: 33105549 PMC: 7690256. DOI: 10.3390/nu12113223.

References
1.
Trinder P . Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969; 22(2):158-61. PMC: 474026. DOI: 10.1136/jcp.22.2.158. View

2.
Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez M, Zarzuelo A, Martinez-Augustin O . Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem. 2010; 401(2):318-20. DOI: 10.1016/j.ab.2010.02.036. View

3.
Haidari M, Leung N, Mahbub F, Uffelman K, Kohen-Avramoglu R, Lewis G . Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and.... J Biol Chem. 2002; 277(35):31646-55. DOI: 10.1074/jbc.M200544200. View

4.
Chan S, Sun R, Zeng X, Choong Z, Wang H, Watt M . Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes. 2013; 62(6):2095-105. PMC: 3661626. DOI: 10.2337/db12-1397. View

5.
Iizuka K . The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism. Nutrients. 2017; 9(2). PMC: 5331612. DOI: 10.3390/nu9020181. View